IonWorks Quattro Automated Patch Clamp System for High-Throughput Ion Channel Screening
Ion channels are a viable and under- represented target class in the pharmaceutical industry. Conventional patch clamping of a single cell at a time, the "gold standard" for studying ion channels, is labor intensive and not amenable to screening large numbers of compounds in early stage drug discovery. As a result, surrogate measures of ion channel activity, such as ligand displacement, ionic flux and membrane potential are used, but these assays cannot maintain a population of ion channels in a particular conformational state due to the lack of voltage control.
Recent advances in planar patch clamp technology commenced the era of ion channel screening using a direct electrophysiological assay, and several instruments are commercially available, including the IonWorks® HT and PatchXpress® 7000A systems from Molecular Devices. Although these systems offer considerably higher throughput than conventional patch clamping, there is still a pressing need to match the throughput of surrogate assays while simultaneously driving down the per compound assay costs. To achieve such a goal, Molecular Devices developed the IonWorks® Quattro™ system with Population Patch Clamp™ (PPC) technology.
Light Signals from Living Cells Fluorescent protein markers delivered under high pressure.Cellular 'Relief Valve' A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.Genomic Signature Shared by Five Types of Cancer National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer. Cat Stem Cell Therapy Gives Humans Hope By the time Bob the cat came to the UC Davis veterinary hospital, he had used up most of his nine lives. Crowdfunding the Fight Against Cancer From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
New Biomarker to Assess Stem Cells Developed A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.A Better Model for Parkinson's Scientists at EPFL solve a longstanding problem with modeling Parkinson’s disease in animals. Using newfound insights, they improve both cell and animal models for the disease, which can propel research and drug development.Faster Drug Discovery? Startup develops more cost-effective test for assessing how cells respond to chemicals.Microalgae Make a Splash in the UK Cosmeceutical Market Scottish innovators have discovered an anti-viral and anti-inflammatory carbohydrate in microscopic algae (microalgae) which has huge potential to change the cosmetics market. Mechanism of Tumor Suppressing Gene Uncovered The most commonly mutated gene in cancer,p53, works to prevent tumor formation by keeping mobile elements in check that otherwise lead to genomic instability, UT Southwestern Medical Center researchers have found.